CpG motifs in bacterial DNA trigger direct B-cell activation
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Unmethylated CpG dinucleotides are more frequent in the genomes of bacteria and viruses than of vertebrates. We report here that bacterial DNA and synthetic oligodeoxynucleotides containing unmethylated CpG dinucleotides induce murine B cells to proliferate and secrete immunoglobulin in vitro and in vivo. This activation is enhanced by simultaneous signals delivered through the antigen receptor. Optimal B-cell activation requires a DNA motif in which an unmethylated CpG dinucleotide is flanked by two 5' purines and two 3' pyrimidines. Oligodeoxynucleotides containing this CpG motif induce more than 95% of all spleen B cells to enter the cell cycle. These data suggest a possible evolutionary link between immune defence based on the recognition of microbial DNA and the phenomenon of 'CpG suppression' in vertebrates. The potent immune activation by CpG oligonucleotides has implications for the design and interpretation of studies using 'antisense' oligonucleotides and points to possible new applications as adjuvants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unmethylated CpG motifs in bacterial DNA are potent triggers of inflammation (Klinman et al., 1997; Krieg et al., 1995).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Krieg et al., 1995
In the citing paper
“CpG DNA is a potent stimulator of TLR9 (12).”
From Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice (2011) · cites this paper as [12]
Citations
Cites
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
Stein, C. A., & Cheng, Y.-C. (1993) · Science · doi:10.1126/science.8351515 · Cited by 1,303
Gene inhibition using antisense oligodeoxynucleotides
Wagner, R. W. (1994) · Nature · doi:10.1038/372333a0 · Cited by 736
CpG islands as gene markers in the vertebrate nucleus
Bird, A. P. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90294-0 · Cited by 678
Current concepts in antisense drug design
Milligan, J. F., Matteucci, M. D., & Martin, J. C. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00066a001 · Cited by 566
Richardson, B., Scheinbart, L., Strahler, J., Gross, L., Hanash, S., & Johnson, M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780331109 · Cited by 562
Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
Agrawal, S., Temsamani, J., & Tang, J. Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7595 · Cited by 561
Therapeutic Applications of Oligonucleotides
Crooke, S. T. (1992) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.32.040192.001553 · Cited by 446
Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA
Messina, J. P., Gilkeson, G. S., & Pisetsky, D. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.6.1759 · Cited by 371
Lymphocyte stimulation: a rapid multiparameter analysis.
Darzynkiewicz, Z., Traganos, F., Sharpless, T., & Melamed, M. R. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.8.2881 · Cited by 347
Frequency of B lymphocytes responsive to anti-immunoglobulin.
Defranco, A. L., Raveche, E. S., Asofsky, R., & Paul, W. E. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.5.1523 · Cited by 293
Research works printed but not linked: 1
- Krapf, F., Herrmann, M., Leitmann, W. & Kalden, J. R. Clin. exp. immun. 75, 336–342 (1989).
Cited by
Items 901–1,000 of 1,013
CpG Oligodeoxynucleotides Induce Murine Macrophages to Up-Regulate Chemokine mRNA Expression
Takeshita, S., Takeshita, F., Haddad, D. E., Ishii, K. J., & Klinman, D. M. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1735 · Cited by 78
Self-citationAtreya, R. N., Bloom, S. L., Scaldaferri, F., Gerardi, V., Admyre, C., Karlsson, A. E., Knittel, T. E., Kowalski, J. H., Lukáš, M., Löfberg, R., et al. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw103 · Cited by 76
Synergistic collaboration between AMPs and non-direct antimicrobial cationic peptides
Ye, Z., Fu, L., Li, S., Chen, Z., Ouyang, J., Shang, X., Liu, Y., Gao, L., & Wang, Y. (2024) · Nature Communications · doi:10.1038/s41467-024-51730-x · Cited by 84
Kant, R., de Vos, W. M., Palva, A., & Satokari, R. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.064220-0 · Cited by 71
Lim, E., Lee, S.-H., Lee, J., Kim, J.-R., Yun, S. S., Baek, S., & Lee, C. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.27 · Cited by 71
A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis
Couzinet, A., Tamura, K., Chen, H.-M., Nishimura, K., Wang, Z., Morishita, Y., Takeda, K., Yagita, H., Yanai, H., Taniguchi, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712295105 · Cited by 71
A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium
Koirala, A., Conley, S. M., & Naash, M. I. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.002 · Cited by 71
Sugai, T., Mori, M., Nakazawa, M., Ichino, M., Naruto, T., Kobayashi, N., Kobayashi, Y., Minami, M., & Yokota, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.09.041 · Cited by 71
An overview of cancer immunotherapy
Davis, I. D. (2000) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2000.00906.x · Cited by 86
Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration
von Beust, B. R., Johansen, P., Smith, K. A., Bot, A., Storni, T., & Kündig, T. M. (2005) · European Journal of Immunology · doi:10.1002/eji.200526124 · Cited by 73
Vollmer, J. (2006) · International Reviews of Immunology · doi:10.1080/08830180600743107 · Cited by 73
Kandimalla, E. R., Yu, D., Zhao, Q., & Agrawal, S. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00316-3 · Cited by 71
Activation of microglia and astrocytes by CpG oligodeoxynucleotides
Takeshita, S., Takeshita, F., Haddad, D. E., Janabi, N., & Klinman, D. M. (2001) · Neuroreport · doi:10.1097/00001756-200110080-00010 · Cited by 71
Self-citationExtracellular DNA and autoimmune diseases
Lou, H., & Pickering, M. C. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.136 · Cited by 75
Kozak, M., & Hu, J. (2023) · Vaccines · doi:10.3390/vaccines11030695 · Cited by 82
A review of CpGs and their relevance to aquaculture
Carrington, A. C., & Secombes, C. J. (2006) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2006.03.015 · Cited by 77
Cyclodextrins in oligonucleotide delivery
Redenti, E., Pietra, C., Gerloczy, A., & Szente, L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00230-7 · Cited by 71
Bae, S. H., Park, Y.-J., Park, J.-B., Choi, Y. S., Kim, M. S., & Sin, J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1838 · Cited by 70
Lyophilization and the Thermostability of Vaccines
Rexroad, J., Wiethoff, C. M., Jones, L. S., & Middaugh, C. R. (2002) · Cell Preservation Technology · doi:10.1089/153834402320882593 · Cited by 70
Eastcott, J. W., Holmberg, C. J., Dewhirst, F. E., Esch, T. R., Smith, D. J., & Taubman, M. A. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00422-9 · Cited by 70
Saito, T. (2004) · Animal Science Journal · doi:10.1111/j.1740-0929.2004.00148.x · Cited by 70
Non‐immunostimulatory nonviral vectors
Liu, F., Shollenberger, L. M., & Huang, L. (2004) · The FASEB Journal · doi:10.1096/fj.04-2187fje · Cited by 70
Vogel, J. C. (2000) · Human Gene Therapy · doi:10.1089/104303400750035780 · Cited by 70
Gao, J. J., Diesl, V., Wittmann, T., Morrison, D. C., Ryan, J. L., Vogel, S. N., & Follettie, M. T. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.6.1234 · Cited by 70
Bridle, A. R., Bütler, R., & Nowak, B. F. (2003) · Journal of Fish Diseases · doi:10.1046/j.1365-2761.2003.00457.x · Cited by 70
Recent advances in the development of immunostimulatory oligonucleotides.
Uhlmann, E., & Vollmer, J. (2003) · PubMed · Cited by 71
Schwartz, D. A., Wohlford-Lenane, C., Quinn, T. J., & Krieg, A. Μ. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.224 · Cited by 70
Self-citationImmunization of animals: from DNA to the dinner plate
Babiuk, L. A., den Hurk, S. V. D. L., & Babiuk, S. (1999) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(99)00132-4 · Cited by 70
Li, W. M., Dragowska, W. H., Bally, M. B., & Schutze-Redelmeier, M.-P. M. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00172-5 · Cited by 69
Cooper, C., & Mackie, D. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.162 · Cited by 72
Jahrsdörfer, B., Jox, R. J., Mühlenhoff, L., Tschoep, K., Krug, A., Rothenfußer, S., Meinhardt, G., Emmerich, B., Endres, S., & Hartmann, G. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.1.83 · Cited by 69
Discovery of novel immunostimulants by dendritic-cell–based functional screening
Mizumoto, N., Gao, J., Matsushima, H., Ogawa, Y., Tanaka, H., & Takashima, A. (2005) · Blood · doi:10.1182/blood-2005-03-1161 · Cited by 73
RIP Links TLR4 to Akt and Is Essential for Cell Survival in Response to LPS Stimulation
Vivarelli, M. S., McDonald, D., Miller, M., Cusson, N., Kelliher, M., & Geha, R. S. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040446 · Cited by 69
Keller, M., Harbottle, R. P., Pérouzel, É., Colin, M., Shah, I., Rahim, A. A., Vaysse, L., Bergau, A., Moritz, S., Brahimi‐Horn, C., et al. (2003) · ChemBioChem · doi:10.1002/cbic.200390049 · Cited by 77
Grüber, C., Nilsson, L. J., & Björkstén, B. (2001) · Pediatric Allergy and Immunology · doi:10.1034/j.1399-3038.2001.1r046.x · Cited by 75
CD40‐dependent and ‐independent activation of human tonsil B cells by CpG oligodeoxynucleotides
Gantner, F., Hermann, P., Nakashima, K., Matsukawa, S., Sakai, K., & Bacon, K. B. (2003) · European Journal of Immunology · doi:10.1002/eji.200323444 · Cited by 68
Cassani, B., Poliani, P. L., Marrella, V., Schena, F., Sauer, A. V., Ravanini, M., Strina, D., Busse, C. E., Regenass, S., Wardemann, H., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091928 · Cited by 75
Brennan, T. V., Lin, L., Brandstadter, J. D., Rendell, V. R., Dredge, K. S., Huang, X., & Yang, Y. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76566 · Cited by 72
Ali, M. F., Dasari, H., Keulen, V. P. V., & Carmona, E. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01504 · Cited by 74
Structure-Dependent Biodistribution of Liposomal Spherical Nucleic Acids
Ferrer, J. R., Sinegra, A. J., Ivancic, D., Yeap, X. Y., Qiu, L., Wang, J.-J., Zhang, Z. J., Wertheim, J. A., & Mirkin, C. A. (2020) · ACS Nano · doi:10.1021/acsnano.9b07254 · Cited by 69
Cavarretta, I. T. R., Mukopadhyay, R., Lonard, D. M., Cowsert, L. M., Bennett, C. F., O’Malley, B. W., & Smith, C. S. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.2.0770 · Cited by 77
Bonato, V. L. D., Gonçalves, E. D. C., Soares, E. G., Júnior, R. R. S., Sartori, A., Coelho‐Castelo, A. A. M., & Silva, C. L. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01931.x · Cited by 68
Electrically mediated delivery of vector plasmid DNA elicits an antitumor effect
Heller, L. C., & Coppola, D. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301802 · Cited by 68
Lanuti, M., Rudginsky, S., Force, S. D., Lambright, E. S., Siders, W., Chang, M. Y., Amin, K. M., Kaiser, L. R., Scheule, R. K., & Albelda, S. Μ. (2000) · PubMed · Cited by 68
Yasuda, K., Ogawa, Y., Kishimoto, M., Takagi, T., Hashida, M., & Takakura, Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00210-3 · Cited by 68
Horner, A. A., & Raz, E. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.129122 · Cited by 68
Marker-free plasmids for biotechnological applications – implications and perspectives
Oliveira, P. H., & Mairhofer, J. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.06.001 · Cited by 67
Brauner, S., Folkersen, L., Kvarnström, M., Meisgen, S., Petersen, S. H., Franzén-Malmros, M., Mofors, J., Brokstad, K. A., Klareskog, L., Jonsson, R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210509 · Cited by 67
Vivinus, S., Baulande, S., van Zanten, M., Campbell, F., Topley, P., Ellis, J. H., Dessen, P., & Coste, H. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02064.x · Cited by 67
Kirschning, C. J., & Bauer, S. (2001) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00128 · Cited by 81
Liang, K. W., Nishikawa, M., Liu, F., Sun, B., Ye, Q., & Huang, L. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302239 · Cited by 67
Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs
Chen, Y., Lenert, P. S., Weeratna, R. D., McCluskie, M. J., Wu, T., Davis, H. L., & Krieg, A. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301482 · Cited by 67
Self-citationTakahashi, N., Kitazawa, H., Iwabuchi, N., Xiao, J. Z., Miyaji, K., Iwatsuki, K., & Saito, T. (2006) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03111.x · Cited by 66
Inhibition of LPS- and CpG DNA-induced TNF-α response by oxidized phospholipids
Ma, Z., Li, J., Yang, L., Mu, Y., Xie, W., Pitt, B., & Li, S. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00220.2003 · Cited by 67
Lenert, P. S. (2010) · Mediators of Inflammation · doi:10.1155/2010/986596 · Cited by 66
Strękowski, L., Say, M., Henary, M., Ruiz, P., Manzel, L. J., Macfarlane, D. E., & Bojarski, A. J. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020374y · Cited by 66
DNA binding to proteolytically activated TLR9 is sequence‐independent and enhanced by DNA curvature
Li, Y., Berke, I. C., & Modis, Y. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.441 · Cited by 74
What Are the Microbial Components Implicated in the Pathogenesis of Sepsis? Report on a Symposium
Horn, D. L., Morrison, D. C., Opal, S. M., Silverstein, R., Visvanathan, K., & Zabriskie, J. B. (2000) · Clinical Infectious Diseases · doi:10.1086/318127 · Cited by 72
Pivotal Advance: Characterization of mouse liver phagocytic B cells in innate immunity
Nakashima, M., Kinoshita, M., Nakashima, H., Habu, Y., Miyazaki, H., Shono, S., Hiroi, S., Shinomiya, N., Nakanishi, K., & Seki, S. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0411214 · Cited by 68
Baumgaertner, P., Costa Nunes, C., Cachot, A., Maby-El Hajjami, H., Cagnon, L., Braun, M., Derré, L., Rivals, J.-P., Rimoldi, D., Gnjatic, S., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1216290 · Cited by 66
The effects of DNA containing CpG motif on dendritic cells
Behboudi, S., Chao, D., Klenerman, P., & Austyn, J. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00979.x · Cited by 68
Patel, B. A., Gomis, S. M., Dar, A. M., Willson, P. J., Babiuk, L. A., Potter, A. A., Mutwiri, G., & Tikoo, S. K. (2008) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2008.02.007 · Cited by 66
Rosa, C. L., Wang, Z., Brewer, J. C., Lacey, S. F., Villacres, M. C., Sharan, R., Krishnan, R., Crooks, M., Markel, S., Maas, R., et al. (2002) · Blood · doi:10.1182/blood-2002-03-0926 · Cited by 69
DOW, S. W., Elmslie, R. E., Fradkin, L. G., Liggitt, D. H., Heath, T. D., Willson, A. P., & Potter, T. A. (1999) · Human Gene Therapy · doi:10.1089/10430349950016375 · Cited by 66
Kemp, T. J., Elzey, B. D., & Griffith, T. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.212 · Cited by 73
Basic Principles of Antisense Therapeutics
Crooke, S. T. (1998) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-58785-6_1 · Cited by 66
Karras, J. G., McGraw, K. R., McKay, R. A., Cooper, S. R., Lerner, D., Lü, T., Walker, C., Dean, N. M., & Monia, B. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5409 · Cited by 66
Targeting danger-associated molecular patterns after myocardial infarction
van Hout, G. P. J., Arslan, F., Pasterkamp, G., & Hoefer, I. E. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1088005 · Cited by 72
The potential of 1018 ISS adjuvant in hepatitis B vaccines
Eng, N. F., Bhardwaj, N., Mulligan, R., & Díaz‐Mitoma, F. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.24715 · Cited by 65
Nonviral Aβ DNA vaccine therapy against Alzheimer’s disease: Long-term effects and safety
Okura, Y., Miyakoshi, A., Kohyama, K., Park, I.-K., Staufenbiel, M., & Matsumoto, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600966103 · Cited by 67
Biomedical Applications of Functionalised Carbon Nanotubes
Bianco, A., Sainz, R., Li, S., Dumortier, H., Lacerda, L., Kostarelos, K., Giordani, S., & Prato, M. (2008) · Carbon materials: chemistry and physics/Carbon materials · doi:10.1007/978-1-4020-6845-4_2 · Cited by 67
Pedras-Vasconcelos, J., Goucher, D., Puig, M., Tonelli, L. H., Wang, V. Y., Ito, S., & Verthelyi, D. I. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4940 · Cited by 71
Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungs
McLachlan, G., Stevenson, B., Davidson, D. J., & Porteous, D. J. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301097 · Cited by 65
Obermeier, F., Strauch, U. G., Dunger, N., Grunwald, N., Rath, H. C., Herfarth, H., Schölmerich, J., & Falk, W. (2005) · Gut · doi:10.1136/gut.2004.046946 · Cited by 65
Kandimalla, E. R. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg343 · Cited by 65
Effective DNA Vaccination Against Listeriosis by Prime/Boost Inoculation with the Gene Gun
Fensterle, J., Grode, L., Hess, J., & Kaufmann, S. H. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4510 · Cited by 65
Ljungberg, K., Rollman, E., Eriksson, L. E., Hinkula, J., & Wahrén, B. (2002) · Virology · doi:10.1006/viro.2002.1547 · Cited by 68
Gunn, J. P., Holt, C. M., Francis, S., Shepherd, L., Grohmann, M. J., Newman, C. M. H., Crossman, D. C., & Cumberland, D. C. (1997) · Circulation Research · doi:10.1161/01.res.80.4.520 · Cited by 65
Efficient in vivo gene transfer by PCR amplified fragment with reduced inflammatory activity
Hofman, C., Dileo, J., Li, Z., Li, S., & Huang, L. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301373 · Cited by 65
Therapeutic Applications of Nucleic Acids and Their Analogues in Toll-like Receptor Signaling
Gosu, V., Basith, S., Kwon, O., & Choi, S. (2012) · Molecules · doi:10.3390/molecules171113503 · Cited by 72
Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21
Lai, C.-Y., Yu, G., Luo, Y., Xiang, R., & Chuang, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00179 · Cited by 66
Adachi, Y., Kindzelskii, A. L., Petty, A. R., Huang, J.-B., Maeda, N., Yotsumoto, S., Aratani, Y., Ohno, N., & Petty, H. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.5033 · Cited by 66
Dil, N., & Marshall, A. J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.03.010 · Cited by 70
Wang, D., Jiang, W. W., Zhu, F., Mao, X., & Agrawal, S. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4456 · Cited by 73
Ashrafizadeh, M., Najafi, M., Kaviyani, N., Mohammadinejad, R., Farkhondeh, T., & Samarghandian, S. (2021) · Inflammation · doi:10.1007/s10753-021-01428-9 · Cited by 67
RetractedMiescher, S., & Vogel, M. T. (2002) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(02)00009-2 · Cited by 64
Xu, H., An, H., Yu, Y., Zhang, M., Qi, R., & Cao, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305698200 · Cited by 64
Bromidge, S. M., Dabbs, S., Davies, D. T., Duckworth, D. M., Forbes, I. T., Ham, P., Jones, G. E., King, F. D., Saunders, D. V., Starr, S., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970741j · Cited by 65
T Cell-Independent Rescue of B Lymphocytes from Peripheral Immune Tolerance
Kouskoff, V., Lacaud, G., & Nemazee, D. A. (2000) · Science · doi:10.1126/science.287.5462.2501 · Cited by 64
Macrophage Activation by Immunostimulatory DNA
Stacey, K. J., Sester, D. P., Sweet, M. J., & Hume, D. A. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59672-8_3 · Cited by 64
Antimetastatic effect of CpG DNA mediated by type I IFN.
Hafner, M., Zawatzky, R., Hirtreiter, C., Buurman, W. A., Echtenacher, B., Hehlgans, T., & Männel, D. N. (2001) · PubMed · Cited by 64
A Protective Allergy Vaccine Based on CpG- and Protamine-Containing PLGA Microparticles
Gómez, J. M. M., Fischer, S., Csaba, N., Kündig, T. M., Merkle, H. P., Gander, B., & Johansen, P. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9318-0 · Cited by 63
Anwar, S., Mir, F., & Yokota, T. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041130 · Cited by 71
Ongoing Clinical Trials of Nonviral siRNA Therapeutics
Narasipura, E. A., VanKeulen‐Miller, R., Ma, Y., & Fenton, O. S. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00205 · Cited by 69
Papapetrou, E. P., Zoumbos, N. C., & Athanassiadou, A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302626 · Cited by 72
Yeh, D., Huang, L.-R., Chen, Y., Huang, C. F., & Chuang, T. (2016) · Journal of Immunology Research · doi:10.1155/2016/4368101 · Cited by 68
Kitazawa, H., Watanabe, H., Shimosato, T., Kawai, Y., Itoh, T., & Saito, T. (2003) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(02)00477-4 · Cited by 63
TLR7 and CD40 cooperate in IL‐6 production via enhanced JNK and AP‐1 activation
Bush, T. J. V., & Bishop, G. A. (2008) · European Journal of Immunology · doi:10.1002/eji.200737602 · Cited by 65
Self-citationKim, R., Emi, M., Matsuura, K., & Tanabe, K. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700986 · Cited by 68
Intracisternally Localized Bacterial DNA Containing CpG Motifs Induces Meningitis
Deng, G.-M., Liu, Z.-Q., & Tarkowski, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4616 · Cited by 64
Metadata
- Authors
- Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M.
- Affiliations
- University of Iowa (US)
- Center for Biologics Evaluation and Research (US)
- ORCID
- Venue
- Nature
- Published
- 1995-04
- Volume
- 374
- Issue
- 6522
- Pages
- 546-549
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2047366876
- Cited by
- 3,508
- References
- 28
- Citations by year
- 2026: 24 · 2025: 36 · 2024: 47 · 2023: 43 · 2022: 58 · 2021: 58 · 2020: 84 · 2019: 84 · 2018: 58 · 2017: 69 · 2016: 76 · 2015: 89 · 2014: 83 · 2013: 102 · 2012: 104
- FWCI
- 36.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- CpG motifs, bacterial DNA, B cell activation, B cell proliferation, immunoglobulin secretion, antigen receptor signaling, CpG oligodeoxynucleotides, CpG suppression, antisense oligonucleotides, adjuvants
- MeSH terms
- Animals, B-Lymphocytes, Base Sequence, Cell Line, DNA, Bacterial, Escherichia coli, Lymphocyte Activation, Methylation, Mice, Inbred DBA, Molecular Sequence Data, Oligodeoxyribonucleotides, T-Lymphocytes, Dinucleoside Phosphates, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.